We are live on ! Find out more
RLAY icon

Relay Therapeutics
RLAY

137 hedge funds and large institutions have $2.96B invested in Relay Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 65 increasing their positions, 26 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 6

150% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 26

19% more funds holding

Funds holding: 115 → 137 (+22)

18% more funds holding in top 10

Funds holding in top 10: 11 → 13 (+2)

0% more call options, than puts

Call options by funds: $17K | Put options by funds: $17K

2.34% less ownership

Funds ownership: 97.46% → 95.12% (-2.3%)

19% less capital invested

Capital invested by funds: $3.64B → $2.96B (-$685M)

Holders
137
Holders Change
+22
Holders Change %
+19.13%
% of All Funds
2.41%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.23%
New
28
Increased
65
Reduced
26
Closed
6
Calls
$17K
Puts
$17K
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$101M
2
DCM
Driehaus Capital Management
Illinois
+$62.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$46.3M
4
DGM
Darwin Global Management
Jersey
+$34M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$31.7M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$439M
2
TGI
TRV GP IV
Massachusetts
-$117M
3
CC
Casdin Capital
New York
-$18.8M
4
PA
Perceptive Advisors
New York
-$13.5M
5
AI
Alphabet Inc
California
-$10.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
76
Credit Suisse
Switzerland
$1.01M -$951K -21,909 -43%
CSS
77
Cubist Systematic Strategies
Connecticut
$995K +$538K +12,387 +76%
FT
78
Fiduciary Trust
Massachusetts
$967K +$1.21M +27,971 New
Manulife (Manufacturers Life Insurance)
79
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$903K +$275K +6,345 +32%
Legal & General Group
80
Legal & General Group
United Kingdom
$893K +$528K +12,157 +89%
IP
81
Intellectus Partners
California
$859K +$656K +15,105 +155%
ProShare Advisors
82
ProShare Advisors
Maryland
$854K +$160K +3,692 +18%
EAM
83
Erste Asset Management
Austria
$822K – – –
Millennium Management
84
Millennium Management
New York
$794K -$2.03M -46,737 -67%
TD Asset Management
85
TD Asset Management
Ontario, Canada
$768K +$168K +3,867 +21%
BFO
86
Boston Family Office
Massachusetts
$730K – – –
BM
87
Brandywine Managers
Delaware
$690K +$508K +11,702 +142%
VOYA Investment Management
88
VOYA Investment Management
Georgia
$686K +$254K +5,849 +42%
Natixis Advisors
89
Natixis Advisors
Massachusetts
$664K +$835K +19,235 New
CC
90
Centiva Capital
New York
$643K +$807K +18,593 New
Jane Street
91
Jane Street
New York
$615K +$772K +17,778 New
MIM
92
MetLife Investment Management
New Jersey
$607K +$166K +3,826 +28%
HS
93
HighVista Strategies
Massachusetts
$583K +$82.5K +1,901 +13%
Nomura Asset Management
94
Nomura Asset Management
Japan
$484K – – –
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
$444K +$148K +3,406 +36%
SFI
96
Susquehanna Fundamental Investments
Pennsylvania
$399K -$882K -20,322 -64%
CF
97
CNA Financial
Illinois
$375K +$114K +2,633 +32%
Marshall Wace
98
Marshall Wace
United Kingdom
$349K +$438K +10,102 New
Wells Fargo
99
Wells Fargo
California
$340K -$581K -13,386 -58%
State Board of Administration of Florida Retirement System
100
State Board of Administration of Florida Retirement System
Florida
$336K +$119K +2,750 +39%
2 3
4
5 6

RLAY Hedge Fund Activity: Q1 2021 in Review

137 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Relay Therapeutics (RLAY) for Q1 2021, worth a combined $2.96B — down 19% from $3.64B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new RLAY positions and 6 closed out — a net gain of 22 holders — while 65 added to existing stakes and 26 trimmed.

The largest buyer was Vanguard Group, adding an estimated $101M. The largest seller was TRV GP III, exiting entirely with an estimated $439M sold.

  • 137 institutional investors held Relay Therapeutics (RLAY) as of Q1 2021, up from 115 in Q4 2020.
  • Funds reported $2.96B of Relay Therapeutics stock for Q1 2021, down 19% quarter-over-quarter.
  • 28 funds opened new Relay Therapeutics positions in Q1 2021 and 6 closed out, a net change of +22 holders.
  • The largest Relay Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $101M added.
  • The largest Relay Therapeutics seller in Q1 2021 was TRV GP III, an estimated $439M sold.

Based on aggregated 13F filings for Q1 2021.